Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma
#911843
ClinicalTrials.gov
Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
#283113
ClinicalTrials.gov
PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma
#356541
ClinicalTrials.gov
CAR-T Immunomonitoring in Multiple Myeloma (CART I5M)
#827526
ClinicalTrials.gov
Study of BCMA CAR-T in Multiple Myeloma
#849915
ClinicalTrials.gov
CURATE.AI Optimized Modulation for Multiple Myeloma
#860365
ClinicalTrials.gov
64Cu-LLP2A for Imaging Multiple Myeloma
#872590
ClinicalTrials.gov
Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma
#890913
ClinicalTrials.gov
MMRF Molecular Profiling Protocol
#893661
ClinicalTrials.gov
Examination of Trends in Multiple Myeloma Trial Patient Experiences
#902203
ClinicalTrials.gov
Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
#890736
ClinicalTrials.gov
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
#898133
ClinicalTrials.gov
LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
#915768
ClinicalTrials.gov
Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
#918788
ClinicalTrials.gov
Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
#968787
ClinicalTrials.gov
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
#442109
ClinicalTrials.gov
Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma
#879243
ClinicalTrials.gov
A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma
#829840
ClinicalTrials.gov
Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma
#841546
ClinicalTrials.gov
Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
#880075
ClinicalTrials.gov
VitD3 Supplementation in Patients With Multiple Myeloma
#992157
ClinicalTrials.gov
Selinexor Treatment of Refractory Myeloma
#181784
ClinicalTrials.gov
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
#913344
ClinicalTrials.gov
PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma
#881711
ClinicalTrials.gov
UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma
#899003
ClinicalTrials.gov
Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
#174880
ClinicalTrials.gov
Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma
#184866
ClinicalTrials.gov
Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma
#426725
ClinicalTrials.gov
The Norwegian Immunotherapy in Multiple Myeloma Study
#432901
ClinicalTrials.gov
Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients
#856770
ClinicalTrials.gov
Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma
#863257
ClinicalTrials.gov
Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients
#881300
ClinicalTrials.gov
Ixazomib + Pomalidomide + Dexamethasone In MM
#881847
ClinicalTrials.gov
A Registry Study of Participants With Multiple Myeloma in Latin America
#916778
ClinicalTrials.gov
ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma
#979038
ClinicalTrials.gov
Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma
#886211
ClinicalTrials.gov
Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
#830369
ClinicalTrials.gov
Immune Fitness in Older Patients With Relapsed and Refractory Multiple Myeloma
#860290
ClinicalTrials.gov
A Study of MCARH109 and MCARH125 in People With Multiple Myeloma
#899527
ClinicalTrials.gov
Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients
#904928
ClinicalTrials.gov
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
#993916
ClinicalTrials.gov
Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma
#18579
ClinicalTrials.gov
Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma
#201790
ClinicalTrials.gov
Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma
#366600
ClinicalTrials.gov
Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma
#474774
ClinicalTrials.gov
GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma
#804577
ClinicalTrials.gov
JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma
#831939
ClinicalTrials.gov
The Molecular Characterization of Multiple Myeloma at Relapse
#841383
ClinicalTrials.gov
A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)
#863937
ClinicalTrials.gov
High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
#878750
ClinicalTrials.gov
← Previous
Page 3 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.